X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

X4 Pharmaceuticals (Nasdaq: XFOR) announced management will participate in the Guggenheim Emerging Outlook: Biotech Summit on February 11–12, 2026 in New York.

Rhea-AI Summary

X4 Pharmaceuticals (Nasdaq: XFOR) announced management will participate in the Guggenheim Emerging Outlook: Biotech Summit on February 11–12, 2026 in New York.

The company will hold a fireside chat on February 12 at 12:30 p.m. ET, offer one-on-one investor meetings, and provide a webcast and 30-day replay on its Investors Events and Presentations page.

Argus Feb 3 session

+0.50% close to close Open Argus

Details

News Market Reaction – XFOR

In the Feb 3 session, XFOR gained 0.50%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights X4’s participation in a Guggenheim biotech summit, including a fireside...

Analysis

This announcement highlights X4’s participation in a Guggenheim biotech summit, including a fireside chat on February 12, 2026 with a webcast replay available for 30 days. In recent months, the company has executed sizeable equity offerings and extended cash runway, while shares trade above the 200-day MA but remain 83.62% below the $24.30 52-week high. Investors may watch for updates on mavorixafor’s Phase 3 development and capital plans at such forums.

Key Figures

Summit dates: February 11–12, 2026 Fireside chat time: 12:30 p.m. ET Webcast replay window: 30 days +1 more

Summit dates

February 11–12, 2026

Guggenheim Emerging Outlook: Biotech Summit participation

Fireside chat time

12:30 p.m. ET

Scheduled on February 12, 2026

Webcast replay window

30 days

Replay available after the fireside chat

Price change

7.57%

Move prior to this conference announcement

Historical Context

5 past events · Latest: Nov 05

5 events

1. Nov 05

   Conference participation

   24h Move

   -10.6%

   Announcement of participation in Guggenheim healthcare innovation conference with webcast access.

2. Nov 05

   Earnings and update

   24h Move

   -10.6%

   Q3 2025 results, major financings and extended cash runway through end of 2028.

3. Oct 27

   Offering closing

   24h Move

   -1.6%

   Closing of underwritten equity offering with $155.3M gross proceeds and higher share count.

4. Oct 24

   Offering pricing

   24h Move

   +23.0%

   Pricing of $135M underwritten public offering at $2.90 per share and pre-funded warrants.

5. Oct 23

   Offering launch

   24h Move

   -0.3%

   Announcement of proposed underwritten public offering to fund Phase 3 mavorixafor.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today announced that the management team will participate in the upcoming Guggenheim Emerging Outlook: Biotech Summit on February 11-12, 2026 in New York.

The X4 team will hold a fireside chat on February 12th at 12:30 p.m. ET and will be available for one-on-one meetings with investors.

A webcast of the fireside chat will be available under the “Events and Presentations” page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit investors.x4pharma.com.

About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare hematology diseases and significant unmet needs. Leveraging expertise in CXCR4, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is currently being marketed in the U.S. as XOLREMDI® in its first indication. The company is also evaluating additional uses of mavorixafor and is conducting a global, pivotal Phase 3 clinical trial (4WARD) in patients with certain chronic neutropenic disorders. X4 is headquartered in Boston, Massachusetts. For more information, please visit www.x4pharma.com.

X4 Investor Contact:
IR@X4pharma.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will X4 Pharmaceuticals (XFOR) present at the Guggenheim Emerging Outlook: Biotech Summit?

X4 will present on February 12, 2026 at 12:30 p.m. ET in a scheduled fireside chat. According to the company, the management team will also be available for one-on-one investor meetings during the February 11–12, 2026 summit in New York.

How can investors watch XFOR's fireside chat from the Guggenheim Biotech Summit on February 12, 2026?

A live webcast of X4's fireside chat will be available via the company’s Investors Events and Presentations page. According to the company, a replay will also be posted and remain accessible for 30 days after the event.

Will X4 Pharmaceuticals (XFOR) meet with investors at Guggenheim Emerging Outlook: Biotech Summit 2026?

Yes. X4 management will be available for one-on-one investor meetings during the February 11–12, 2026 summit. According to the company, interested investors should coordinate meetings through the investor relations contact or the Events and Presentations page.

Where can I find the replay of X4 Pharmaceuticals' (XFOR) Guggenheim summit presentation after the event?

The replay will be posted on X4's Investors Events and Presentations page and available for 30 days. According to the company, investors can access the replay and related materials from investors.x4pharma.com following the event.

What topics will X4 Pharmaceuticals (XFOR) cover at the Guggenheim Emerging Outlook: Biotech Summit on February 12, 2026?

The company will present a management fireside chat focused on corporate updates and investor engagement. According to the company, the session will include management discussion and one-on-one meeting availability for investors at the summit.

Is attendance or registration required to view X4 Pharmaceuticals' (XFOR) Guggenheim summit webcast on February 12, 2026?

The webcast will be posted publicly on the company’s Investors Events and Presentations page for viewing. According to the company, no separate summit registration is required to access the webcast and its 30-day replay online.